Pakistan Pharma Guide -

Always consult a registered medical practitioner. The author does not endorse specific brands mentioned for commercial purposes. | Rank | City | Specialization | | :--- | :--- | :--- | | 1 | Karachi (SITE/Korangi) | API & Finished Goods (70% of national production) | | 2 | Lahore (Sundar/Raiwind) | Formulations & Syrups | | 3 | Islamabad/Rawalpindi | Biotech & Vaccines (NIBGE) | | 4 | Peshawar (Hayatabad) | Export hub to Afghanistan | | 5 | Faisalabad | Veterinary drugs | Download the PDF version of this Pakistan Pharma Guide for offline reference. [Link to PDF]

By [Author Name] Published: [Date] Introduction: An Industry at the Crossroads In the labyrinth of Pakistan’s economy, one sector stands resilient yet strained: Pharmaceuticals . Worth over $3.5 billion and growing at a compound annual rate of approximately 10-12%, the Pakistani pharma industry is the 8th largest manufacturer of Active Pharmaceutical Ingredients (APIs) in Asia and a critical lifeline for over 220 million people.

Alongside them are the local heavyweights: , Getz Pharma , Ferozsons , Highnoon , and Martin Dow . Notably, Getz Pharma has broken the local ceiling by becoming a regional exporter, proving that Pakistani formulations can compete globally.

Over 700 registered pharma companies operate in Pakistan. However, nearly 80% of the market share is held by the top 30 players. The rest are "garage start-ups"—small units often operating on thin margins, producing generics in non-compliant environments. Chapter 2: The Price War (Drug Pricing & Regulation) If there is a single sword hanging over every CEO’s head, it is the Drug Pricing Policy . The Drug Regulatory Authority of Pakistan (DRAP) is the gatekeeper.

But behind the blister packs and IV drips lies a complex ecosystem of regulatory hurdles, price controls, export ambitions, and a silent epidemic of counterfeit drugs.